Skip to main content
David Rimm, MD, Pathology, New Haven, CT

DavidLRimmMD

Pathology New Haven, CT

Cytopathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology, Yale University School of Medicine

Dr. Rimm is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rimm's full profile

Already have an account?

  • Office

    310 Cedar St
    # Lauder
    New Haven, CT 06510
    Phone+1 203-785-3624
    Fax+1 203-785-7037

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1989 - 1993
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1989
  • University of Wisconsin-Madison
    University of Wisconsin-MadisonB.S., with Honors, 1977 - 1981

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1992 - 2025
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Cytopathology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2014
  • Top Doctors: New York Metro Area Castle Connolly, 2014
  • America's Top Doctors for Cancer Castle Connolly, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer Immunotherapy  
    David L Rimm, Agedi N Boto, Roy S Herbst, Nature
  • An International Multicenter Study to Evaluate Reproducibility of Automated Scoring for Assessment of Ki67 in Breast Cancer  
    Richard Levenson, David L Rimm, Daniel F Hayes, Chad Galderisi, Liron Pantanowitz, Nature
  • Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer  
    Guoping Cai, Sarah B Goldberg, Scott Gettinger, Anne Chiang, Roy S Herbst, David L Rimm, Kurt Schalper, Richard Lifton, Clinical Cancer Research
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Rimm,D.L., San Antonio, TX, 1/8/2011
  • VanHouten, J., Sullivan, C., Bazinet, C., Ryoo, T., Camp, R., Rimm, D.L., Chung, G., and Wysolmerski, J, Proc Natl Acad Sci, 1/1/2010
  • Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT, Proc Natl Acad Sci, 1/1/2009
  • Join now to see all

Lectures

  •  
    Athens, Greece - 1/30/2015
  •  
    Philadelphia, PA - 1/30/2015
  •  
    Bethesda, MD - 1/30/2015
  • Join now to see all

Authored Content

  • HER2-Low, a Separate Entity?December 2022

Press Mentions

  • HER2 and Lung Cancer: New Test Holds Great Promise to Help Far More Patients
    HER2 and Lung Cancer: New Test Holds Great Promise to Help Far More PatientsSeptember 26th, 2024
  • 2023 ‘Top Doctors’ List Features Over 250 Yale Medicine Physicians
    2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023
  • Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center Physicians
    Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
  • Join now to see all

Grant Support

  • Predicting Metastasis In MelanomaNational Cancer Institute2006–2012
  • Shared Resources-Critical Technologies For Tissue ServicesNational Cancer Institute2007–2011
  • Optimal Predictors Of Response To TrastuzumabNational Cancer Institute2009–2010
  • Predicting Metastasis To Lymph NodesNational Cancer Institute2005–2008
  • Prediction Of Breast Cancer Response To Hormonal ThearpyNational Cancer Institute2004–2007
  • Predicting Metastisis To Lymph NodesNational Cancer Institute2006
  • AQUA: A New Quantitative In Situ Proteomic AssayNational Cancer Institute2003–2004
  • Establishment And Regulation Of Cell/Cell AdhesionNational Institute Of General Medical Sciences1998–2002
  • Value Of MET For Prediction Of Metastasis In CancerNational Cancer Institute1999–2000
  • QB Cytology, Method For Detect Circulating Cancer CellsNational Cancer Institute1999–2000
  • Molecular Clonality Assay For Early Cancer DiagnosisNational Cancer Institute1999–2000
  • Role Of Beta Catenin Activation In Progression And Prognosis Of MelanomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999